Benzoic Acid

Benzoic Acid

SCHEMBL17799552

CCCCC(N)=O.O=C(O)c1ccccc1

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CACNA1CCACNA1DCACNA1FCACNA1SDPP4HTR1BHTR1D

The experimentally established mechanism targets of Benzoic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CES2 O00748 5/20 0.59
CES1 P23141 5/20 0.59
TSHR P16473 2/20 0.54
DAO P14920 1/20 0.54
NAPRT Q6XQN6 1/20 0.54
PTGS2 P35354 1/20 0.52
ALDH1A1 P00352 1/20 0.49
LTB4R2 Q9NPC1 1/20 0.48
RARB P10826 2/20 0.47
SRD5A2 P31213 1/20 0.47
KDM4E B2RXH2 1/20 0.46
MEN1 O00255 1/20 0.46
RECQL P46063 1/20 0.46
KMT2A Q03164 1/20 0.46
NAAA Q02083 1/20 0.46
TP53 P04637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzoic Acid SCHEMBL28678293 0.94 CES2 (0.61) CES2CES1TSHRDAONAPRT
Nonanoamide SCHEMBL27583769 0.93 CES2 (0.62) CES2CES1TSHRDAONAPRT
Benzoic Acid SCHEMBL30453578 0.90 TSHR (0.56) CES2CES1TSHRDAONAPRT
Benzoic Acid SCHEMBL5787758 0.86 CES2 (0.61) CES2CES1TSHRDAONAPRT
Benzoic Acid SCHEMBL6573567 0.86 TSHR (0.67) CES2CES1TSHRDAONAPRT
Benzoic Acid SCHEMBL27413851 0.86 TSHR (0.67) CES2CES1TSHRDAONAPRT
Benzoic Acid SCHEMBL9594281 0.86 TSHR (0.67) CES2CES1TSHRDAONAPRT
Benzoic Acid SCHEMBL9157936 0.86 TSHR (0.67) CES2CES1TSHRDAONAPRT
Benzoic Acid SCHEMBL28845500 0.86 TSHR (0.67) CES2CES1TSHRDAONAPRT
Benzoic Acid SCHEMBL28961676 0.85 CES2 (0.59) CES2CES1TSHRDAONAPRT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10092537-B2 Use for PAI-1 inhibitor RENASCIENCE CO., LTD. (JP) 2018-10-09 US disclosed
US-20160158188-A1 NOVEL USE FOR PAI-1 INHIBITOR RENASCIENCE CO., LTD. (JP) 2016-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160158188-A1 NOVEL USE FOR PAI-1 INHIBITOR SERPINE1, SERPINC1, SERPINB1 CES2 3394/4885CES1 582/4885TSHR 3711/4885
US-10092537-B2 Use for PAI-1 inhibitor SERPINE1, SERPINC1, SERPINB1 CES2 3150/4885CES1 530/4885TSHR 3756/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.